DexCom Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), DexCom Inc. reported revenue of $4.7B (+15.6% year on year) and net income of $836.3M (+45.1% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenue | $4.7B | $4.0B | $3.6B | $2.9B |
| Cost of sales | $1.9B | $1.6B | $1.3B | $1.0B |
| Gross profit | $2.8B | $2.4B | $2.3B | $1.9B |
| Research and development | $599.1M | $552.4M | $505.8M | $484.2M |
| Selling, general and administrative | $1.3B | $1.3B | $1.2B | $1.0B |
| Total operating expenses | $1.9B | $1.8B | $1.7B | $1.5B |
| Operating income | $911.8M | $600.0M | $597.7M | $391.2M |
| Other income, net | $176.6M | $109.0M | $112.7M | $18.0M |
| Income before income taxes | $1.1B | $709.0M | $710.4M | $390.8M |
| Income tax expense | $252.1M | $132.8M | $168.9M | $49.6M |
| Net income | $836.3M | $576.2M | $541.5M | $341.2M |
| Basic net income per share (in usd per share) | $2.14 | $1.46 | $1.40 | $0.88 |
| Shares used to compute basic net income per share (in shares) | $390200000.00 | $393600000.00 | $386000000.00 | $389400000.00 |
| Diluted net income per share (in usd per share) | $2.09 | $1.42 | $1.30 | $0.82 |
| Shares used to compute diluted net income per share (in shares) | $405500000.00 | $412700000.00 | $425500000.00 | $427500000.00 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.2B | $1.2B |
| Cost of sales | $478.4M | $441.6M | $477.9M | $468.3M |
| Gross profit | $830.0M | $750.3M | $731.4M | $688.8M |
| Research and development | $153.0M | $145.3M | $157.5M | $148.2M |
| Selling, general and administrative | $358.7M | $349.7M | $331.4M | $328.0M |
| Total operating expenses | $511.7M | $495.0M | $488.9M | $476.2M |
| Operating income | $318.3M | $255.3M | $242.5M | $212.6M |
| Other income (expense), net | ($800.0K) | $14.2M | $109.8M | $28.5M |
| Income before income taxes | $317.5M | $269.5M | $352.3M | $241.1M |
| Income tax expense | $68.4M | $70.0M | $68.5M | $61.3M |
| Net income | $249.1M | $199.5M | $283.8M | $179.8M |
| Basic net income per share (in USD per share) | $0.65 | $0.52 | $0.73 | $0.46 |
| Shares used to compute basic net income per share (in shares) | $382200000.00 | $385100000.00 | $391100000.00 | $392100000.00 |
| Diluted net income per share (in USD per share) | $0.64 | $0.51 | $0.70 | $0.45 |
| Shares used to compute diluted net income per share (in shares) | $390100000.00 | $393600000.00 | $407400000.00 | $408200000.00 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $917.7M | $606.1M | $566.3M | $642.3M |
| Short-term marketable securities | $1.1B | $2.0B | $2.2B | $1.8B |
| Accounts receivable, net | $1.2B | $1.0B | $973.9M | $713.3M |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M |
| Prepaid and other current assets | $189.4M | $173.7M | $168.3M | $192.6M |
| Total current assets | $4.0B | $4.3B | $4.4B | $3.7B |
| Property and equipment, net | $1.6B | $1.3B | $1.1B | $1.1B |
| Operating lease right-of-use assets | $77.4M | $62.8M | $71.4M | $80.0M |
| Goodwill | $24.2M | $22.8M | $25.2M | $25.7M |
| Intangibles, net | $70.8M | $103.4M | $134.5M | $173.3M |
| Deferred tax assets | $295.6M | $481.2M | $419.4M | $341.2M |
| Other assets | $278.7M | $173.0M | $75.0M | $47.1M |
| Total assets | $6.3B | $6.5B | $6.3B | $5.4B |
| Accounts payable and accrued liabilities | $1.9B | $1.6B | $1.3B | $901.8M |
| Accrued payroll and related expenses | $169.2M | $112.0M | $171.0M | $134.3M |
| Current portion of long-term senior convertible notes | $0 | $1.2B | $0 | $772.6M |
| Short-term operating lease liabilities | $21.6M | $22.5M | $21.1M | $20.5M |
| Other current liabilities | $7.7M | — | — | — |
| Total current liabilities | $2.1B | $2.9B | $1.6B | $1.8B |
| Long-term senior convertible notes | $1.2B | $1.2B | $2.4B | $1.2B |
| Long-term operating lease liabilities | $73.4M | $65.0M | $80.1M | $94.6M |
| Other long-term liabilities | $137.1M | $147.9M | $125.6M | $128.3M |
| Total liabilities | $3.6B | $4.4B | $4.2B | $3.3B |
| Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December 31, 2025 and December 31, 2024 | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value, 800.0 million shares authorized; 410.7 million and 384.8 million shares issued and outstanding, respectively, at December 31, 2025; and 408.9 million and 390.7 million shares issued and outstanding, respectively, at December 31, 2024 | 400.0K | 400.0K | 400.0K | 400.0K |
| Additional paid-in capital | $2.3B | $2.1B | $3.5B | $2.3B |
| Accumulated other comprehensive income (loss) | $115.0M | ($8.0M) | ($16.7M) | ($11.6M) |
| Retained earnings | $2.4B | $1.6B | $1.0B | $479.9M |
| Treasury stock, at cost; 25.9 million shares at December 31, 2025 and 18.2 million shares at December 31, 2024 | -2.1B | -1.6B | -2.5B | -595.0M |
| Total stockholders’ equity | $2.7B | $2.1B | $2.1B | $2.1B |
| Total liabilities and stockholders’ equity | $6.3B | $6.5B | $6.3B | $5.4B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.1B | $1.1B | $1.8B | $1.2B |
| Short-term marketable securities | $842.0M | $1.3B | $1.5B | $1.8B |
| Accounts receivable, net | $1.3B | $1.1B | $1.1B | $1.3B |
| Inventory | $726.4M | $693.6M | $604.1M | $570.7M |
| Prepaid and other current assets | $155.5M | $134.3M | $183.7M | $181.4M |
| Total current assets | $4.1B | $4.3B | $5.2B | $5.0B |
| Property and equipment, net | $1.6B | $1.6B | $1.5B | $1.5B |
| Operating lease right-of-use assets | $88.0M | $73.1M | $54.0M | $56.4M |
| Goodwill | $24.1M | $24.2M | $24.1M | $24.1M |
| Intangibles, net | $101.6M | $62.6M | $79.0M | $87.2M |
| Deferred tax assets | $304.1M | $296.1M | $375.6M | $496.3M |
| Other assets | $273.7M | $285.9M | $276.5M | $175.5M |
| Total assets | $6.5B | $6.6B | $7.5B | $7.3B |
| Accounts payable and accrued liabilities | $2.2B | $2.1B | $1.9B | $1.9B |
| Accrued payroll and related expenses | $136.3M | $121.8M | $170.2M | $129.3M |
| Short-term operating lease liabilities | $20.7M | $20.5M | $23.6M | $23.4M |
| Other current liabilities | $9.2M | $7.6M | — | — |
| Total current liabilities | $2.4B | $2.2B | $3.3B | $3.3B |
| Long-term senior convertible notes | $1.2B | $1.2B | $1.2B | $1.2B |
| Long-term operating lease liabilities | $82.6M | $69.0M | $50.6M | $54.7M |
| Other long-term liabilities | $150.8M | $141.8M | $147.4M | $151.6M |
| Total liabilities | $3.8B | $3.7B | $4.8B | $4.8B |
| Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value, 800.0 million shares authorized; 412.4 million and 377.4 million shares issued and outstanding, respectively, at June 30, 2026; and 410.7 million and 384.8 million shares issued and outstanding, respectively, at December 31, 2025 | 400.0K | 400.0K | 400.0K | 400.0K |
| Additional paid-in capital | $2.4B | $2.3B | $2.2B | $2.2B |
| Accumulated other comprehensive income | $90.0M | $106.2M | $81.5M | $83.6M |
| Retained earnings | $2.9B | $2.6B | $2.2B | $1.9B |
| Treasury stock, at cost; 35.0 million shares at June 30, 2026 and 25.9 million shares at December 31, 2025 | -2.7B | -2.1B | -1.8B | -1.6B |
| Total stockholders’ equity | $2.6B | $3.0B | $2.7B | $2.6B |
| Total liabilities and stockholders’ equity | $6.5B | $6.6B | $7.5B | $7.3B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $836.3M | $576.2M | $541.5M | $341.2M |
| Depreciation and amortization | $251.8M | $217.7M | $186.0M | $155.9M |
| Share-based compensation | $159.6M | $170.4M | $150.8M | $126.5M |
| Non-cash interest expense | $7.3M | $7.5M | $7.8M | $6.3M |
| Deferred income taxes | $182.2M | ($43.8M) | ($55.0M) | ($21.6M) |
| Net (gains) losses on equity investments | ($78.1M) | — | — | — |
| Other non-cash income and expenses | ($21.8M) | ($47.3M) | ($83.9M) | $34.7M |
| Accounts receivable, net | ($201.9M) | ($35.0M) | ($260.1M) | ($199.9M) |
| Inventory | ($63.7M) | $12.4M | ($252.6M) | $49.3M |
| Prepaid and other assets | ($14.8M) | ($5.8M) | $19.3M | ($131.6M) |
| Operating lease right-of-use assets and liabilities, net | ($7.1M) | ($6.5M) | ($4.5M) | ($5.8M) |
| Accounts payable and accrued liabilities | $347.0M | $211.7M | $466.5M | $295.1M |
| Accrued payroll and related expenses | $55.4M | ($60.0M) | $37.2M | $8.5M |
| Deferred revenue and other liabilities | ($11.5M) | ($8.0M) | ($2.6M) | $11.1M |
| Net cash provided by operating activities | $1.4B | $989.5M | $748.5M | $669.5M |
| Purchases of marketable securities | ($1.2B) | ($2.6B) | ($3.2B) | ($2.3B) |
| Proceeds from sale and maturity of marketable securities | $2.2B | $2.8B | $2.9B | $2.1B |
| Purchases of property and equipment | ($363.5M) | ($358.8M) | ($236.6M) | ($364.8M) |
| Purchases of non-marketable equity securities | ($19.2M) | ($81.3M) | — | — |
| Other investing activities | $600.0K | ($15.5M) | ($17.6M) | ($14.3M) |
| Net cash provided by (used in) investing activities | $536.0M | ($207.5M) | ($507.2M) | ($521.5M) |
| Net proceeds from issuance of common stock | $28.1M | $28.2M | $26.6M | $22.5M |
| Purchases of treasury stock | ($500.0M) | ($750.0M) | ($688.7M) | ($557.7M) |
| Proceeds from issuance of convertible notes, net of issuance costs | $0 | $0 | $1.2B | $0 |
| Purchases of capped call transactions | $0 | $0 | ($101.3M) | — |
| Payments for conversions of senior convertible notes | $0 | $0 | ($787.3M) | — |
| Repayments for maturity of senior convertible notes | ($1.2B) | — | — | — |
| Other financing activities | ($7.0M) | ($13.0M) | $1.5M | ($17.3M) |
| Net cash used in financing activities | ($1.7B) | ($734.8M) | ($318.6M) | ($552.5M) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | $21.5M | ($7.4M) | $1.5M | ($5.8M) |
| Increase (decrease) in cash, cash equivalents and restricted cash | $311.8M | $39.8M | ($75.8M) | ($410.3M) |
| Cash, cash equivalents and restricted cash, beginning of period | $607.3M | $567.5M | $643.3M | $1.1B |
| Cash, cash equivalents and restricted cash, end of period | $919.1M | $607.3M | $567.5M | $643.3M |
| Cash and cash equivalents | $917.7M | $606.1M | $566.3M | $642.3M |
| Restricted cash | $1.4M | $1.2M | $1.2M | $1.0M |
| Total cash, cash equivalents and restricted cash | $919.1M | $607.3M | $567.5M | $643.3M |
| Shares issued for repurchase and conversions of senior convertible notes | 0 | 0 | 1.5B | 35.9M |
| Shares received under note hedge upon conversion of 2023 Notes | 0 | 0 | -1.5B | -33.5M |
| Acquisition of property and equipment included in accounts payable and accrued liabilities | $62.7M | $75.4M | $53.2M | $25.7M |
| Cash paid during the year for interest | $11.4M | $11.4M | $12.4M | $12.2M |
| Cash paid during the year for income taxes | $94.4M | $198.0M | $212.3M | $114.2M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $448.6M | $199.5M | $569.0M | $285.2M |
| Depreciation and amortization | $135.3M | $67.1M | $186.6M | $123.0M |
| Share-based compensation | $82.3M | $43.3M | $124.6M | $79.5M |
| Non-cash interest expense | $2.0M | $1.0M | $5.6M | $3.7M |
| Deferred income taxes | $0 | $300.0K | $103.3M | ($14.7M) |
| Net losses on equity investments | $10.0M | $0 | ($78.1M) | — |
| Other non-cash income and expenses | ($200.0K) | $0 | ($18.7M) | ($12.7M) |
| Accounts receivable, net | ($47.5M) | $124.6M | ($95.7M) | ($333.5M) |
| Inventory | ($101.6M) | ($65.2M) | ($45.9M) | ($12.3M) |
| Prepaid and other assets | $31.9M | $51.0M | ($7.9M) | ($5.5M) |
| Operating lease right-of-use assets and liabilities, net | ($2.3M) | ($1.3M) | ($4.5M) | ($3.0M) |
| Accounts payable and accrued liabilities | $258.0M | $145.1M | $357.1M | $359.4M |
| Accrued payroll and related expenses | ($32.1M) | ($47.1M) | $56.6M | $15.3M |
| Deferred revenue and other liabilities | $10.4M | $7.3M | ($5.3M) | $2.4M |
| Net cash provided by operating activities | $794.8M | $525.6M | $1.1B | $486.8M |
| Purchases of marketable securities | ($758.7M) | ($688.6M) | ($1.2B) | ($1.1B) |
| Proceeds from sale and maturity of marketable securities | $994.0M | $468.2M | $1.8B | $1.3B |
| Purchases of property and equipment | ($161.3M) | ($76.6M) | ($261.6M) | ($181.1M) |
| Acquisitions, net of cash acquired | ($41.2M) | — | — | — |
| Purchases of non-marketable equity securities | ($1.5M) | ($1.5M) | ($18.0M) | — |
| Other investing activities | $0 | $0 | $500.0K | ($500.0K) |
| Net cash provided by investing activities | $31.3M | ($298.5M) | $229.4M | $36.6M |
| Net proceeds from issuance of common stock | $12.7M | $12.7M | $28.1M | $14.2M |
| Purchases of treasury stock | ($603.6M) | — | ($187.2M) | — |
| Payments for taxes related to net share settlement of equity awards | ($37.6M) | ($35.8M) | — | — |
| Other financing activities | ($3.8M) | ($1.9M) | ($5.1M) | ($3.4M) |
| Net cash provided by (used in) financing activities | ($632.3M) | ($25.0M) | ($164.2M) | $10.8M |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ($7.7M) | ($2.8M) | $17.7M | $18.8M |
| Increase in cash, cash equivalents and restricted cash | $186.1M | $199.3M | $1.2B | $553.0M |
| Cash, cash equivalents and restricted cash, beginning of period | $919.1M | $919.1M | $607.3M | $607.3M |
| Cash, cash equivalents and restricted cash, end of period | $1.1B | $1.1B | $1.8B | $1.2B |
| Cash and cash equivalents | $1.1B | $1.1B | $1.8B | $1.2B |
| Restricted cash | $200.0K | $200.0K | $1.2M | $1.3M |
| Total cash, cash equivalents and restricted cash | $1.1B | $1.1B | $1.8B | $1.2B |
| Acquisition of property and equipment included in accounts payable and accrued liabilities | $55.2M | $50.4M | $46.4M | $51.7M |
| Right-of-use assets obtained in exchange for operating lease liabilities | $20.0M | $400.0K | $2.7M | $500.0K |
| Right-of-use assets obtained in exchange for finance lease liabilities | $2.6M | $2.0M | $1.4M | $1.4M |
DexCom Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.